Found 67 articles for: "COVID"
Final Test Article
May 2016 | Volume 15 | Issue 5 | Original Article | 654 | Copyright © May 2016
TEST TEXT Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional informatio...
Read MoreTest Article 101
May 2016 | Volume 15 | Issue 5 | Original Article | 654 | Copyright © May 2016
TEST TEXT Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatologic community. This department may include additional informatio...
Read MoreTest Article 5
May 2016 | Volume 15 | Issue 5 | Original Article | ABC Test First | Copyright © May 2016
Abstract Test Text...
Read MoreMark G. - Test
December 2021 | Volume 20 | Issue 12 | Original Article | 1 | Copyright © December 2021
This is an abstract
This is an abstract update...
Read MoreTesting Test Article 300
December 2021 | Volume 20 | Issue 12 | Original Article | First Page Test | Copyright © December 2021
Abstract Test text...
Read MoreOptimizing Outcomes With the 1550/1927 nm Dual Wavelength Non-Ablative Fractional Laser: Experienced User Recommendations
November 2021 | Volume 20 | Issue 11 | Original Article | 1150 | Copyright © November 2021
Background: Fractional laser treatment was introduced in 2004 as a non-invasive technique to treat sun-damaged and aging skin. Since then, numerous ablative and non-ablative photother...
Read MoreINDIVIDUAL ARTICLE: Algorithm for Nonenergy and Injectable Treatment Pre-/Post-Procedure Measures
November 2021 | Volume 20 | Issue 11 | Supplement Individual Articles | ss3s | Copyright © November 2021
Background: Nonenergy and injectable treatments are frequently used for facial rejuvenation. Many publications have addressed methods to reduce adverse events related to the procedure...
Read MoreBiological Therapy Interruption and Re-Treatment in Chronic Plaque Psoriasis
October 2021 | Volume 20 | Issue 10 | Original Article | 1063 | Copyright © October 2021
While biological treatments for chronic plaque psoriasis should be administered continuously to maximize and maintain efficacy, interruptions in therapy may be necessary for a number of reasons. We re...
Read MoreHolistic and Integrative Methods for Diagnosing and Treating the Underlying Causes of Inflammatory Skin Diseases
October 2021 | Volume 20 | Issue 10 | Features | 1121 | Copyright © October 2021
While the majority of patients are helped by current dermatologic therapy, there are a number of patients who find no relief, or are afraid of the side effects of powerful immunosuppressants that do n...
Read MoreTherapeutic Recommendations for the Treatment of Toenail Onychomycosis in the US
October 2021 | Volume 20 | Issue 10 | Original Article | 1076 | Copyright © October 2021
Background: Onychomycosis affects around 14% of individuals in North America and Europe and is undertreated. Treatment is challenging as toenail growth can take 12–18 months, th...
Read MoreRacial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
September 2021 | Volume 20 | Issue 9 | Original Article | 932 | Copyright © September 2021
Background: Genetic and environmental factors influence stratum corneum (SC) barrier properties and function. Researchers increasingly focus on biophysical studies that may help clini...
Read MoreHealth Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
September 2021 | Volume 20 | Issue 9 | Editorials | 1009 | Copyright © September 2021
A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars
September 2021 | Volume 20 | Issue 9 | Original Article | 964 | Copyright © September 2021
Keloid and hypertrophic scars are fibroproliferative disorders resulting from abnormal wound healing in genetically susceptible individuals. Current therapies are often ineffective. Kynurenine shows p...
Read MoreMask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
September 2021 | Volume 20 | Issue 9 | Editorials | 1013 | Copyright © September 2021
AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
September 2021 | Volume 20 | Issue 9 | Original Article | 980 | Copyright © September 2021
THIS IS SE
Objective: To evaluate the efficacy and safety of AbobotulinumtoxinA (ABO) dose escalation in the correction of moderate-to-severe glabellar lines.
Desig...
Read MoreCOVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients
August 2021 | Volume 20 | Issue 8 | Editorials | 914 | Copyright © August 2021
Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects....
Read MoreHerpes Zoster Following COVID-19 Vaccination
August 2021 | Volume 20 | Issue 8 | Case Reports | 898 | Copyright © August 2021
Vaccination is an important intervention in preventing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Messenger RNA (mRNA) vaccines from Pfizer™ and Moderna™ a...
Read MoreProceedings Report of the Fifth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2020
August 2021 | Volume 20 | Issue 8 | Original Article | 868 | Copyright © August 2021
The Symposium on Hidradenitis Suppurativa Advances (SHSA) is a joint meeting of the United States Hidradenitis Suppurativa Foundation (HSF) and the Canadian Hidradenitis Suppurativa Foundation (CHSF)....
Read MoreCombining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
August 2021 | Volume 20 | Issue 8 | Case Reports | 901 | Copyright © August 2021
Anti-epidermal growth factor receptor (EGFR) antibodies and anti-programmed cell death 1 protein (PD-1) antibodies have been used separately to treat metastatic cutaneous squamous cell carcinoma (cSCC...
Read MoreUnderstanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2
July 2021 | Volume 20 | Issue 7 | Editorials | 806 | Copyright © July 2021
